Solid Tumors Stocks List Ranked for 2024 | NYSE,

Symbol	Grade	Name	% Change
INBX	D	Inhibrx, Inc.	0.41
KURA	D	Kura Oncology, Inc.	0.19
KYMR	D	Kymera Therapeutics, Inc.	3.03
LGND	D	Ligand Pharmaceuticals Incorporated	2.18
CLRB	D	Cellectar Biosciences, Inc.	2.40
CNTA	D	Centessa Pharmaceuticals plc	-0.84
IOVA	D	Iovance Biotherapeutics, Inc.	5.82
ARGX	D	argenx SE	-1.33
ACLX	D	Arcellx, Inc.	-1.13
GMAB	D	Genmab A/S	7.22

Symbol	Grade	Name	Weight
FRNW	D	Fidelity Clean Energy ETF	1.37
PBD	D	PowerShares Global Clean Energy Portfolio	1.1
GERM	C	ETFMG Treatments Testing and Advancements ETF	0.73
RNRG	D	Global X Renewable Energy Producers ETF	0.66
TAN	D	Invesco Solar ETF	0.62

Compare ETFs

Compare FRNW to GERM Compare PBD to GERM Compare PBD to TAN

Date	Stock	Title
May 3	GMAB	Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript
May 3	KYMR	Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q1 2024 Earnings Call Transcript
May 3	LGND	Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
May 3	KYMR	Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
May 3	KYMR	Wall Street Analysts Predict a 34.41% Upside in Kymera Therapeutics (KYMR): Here's What You Should Know
May 3	LGND	Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises
May 3	KYMR	Kymera Therapeutics, Inc. (KYMR) Q1 2024 Earnings Call Transcript
May 3	KURA	Kura Oncology Inc (KURA) (Q1 2024) Earnings Call Transcript Highlights: Key Financial and ...
May 3	KYMR	Kymera Therapeutics Inc (KYMR) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
May 2	GMAB	Genmab A/S (GMAB) Q1 2024 Earnings Call Transcript
May 2	KURA	Kura Oncology GAAP EPS of -$0.59 misses by $0.03
May 2	KURA	Kura Oncology Reports First Quarter 2024 Financial Results
May 2	GMAB	Genmab A/S 2024 Q1 - Results - Earnings Call Presentation
May 2	LGND	Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates
May 2	LGND	Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates
May 2	LGND	Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
May 2	GMAB	Genmab reports Q1 results
May 2	GMAB	Genmab Announces Financial Results for the First Quarter of 2024
May 2	LGND	Novo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales
May 2	KYMR	Kymera Therapeutics GAAP EPS of -$0.69 beats by $0.04, revenue of $10.3M misses by $2.75M

Solid Tumors: Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).